Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
32 hedge funds and large institutions have $25.1M invested in Biolase, Inc. in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 4 closing their positions.
6% less funds holding
Funds holding: 34 → 32 (-2)
48% less capital invested
Capital invested by funds: $48.1M → $25.1M (-$23M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$725K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$37.2K |
| 3 |
Goldman Sachs
New York
|
+$18.6K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$18.6K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$18.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$130K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
-$112K |
| 3 |
QSS
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
|
-$105K |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$92.9K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$45K |
BIOL Hedge Fund Activity: Q3 2015 in Review
32 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q3 2015, worth a combined $25.1M — down 48% from $48.1M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BIOL and 2 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 3 added.
The largest buyer was Consonance Capital Management, adding an estimated $725K. The largest seller was Bank of New York Mellon, cutting an estimated $130K.
- 32 institutional investors held Biolase, Inc. (BIOL) as of Q3 2015, down from 34 in Q2 2015.
- Funds reported $25.1M of Biolase, Inc. stock for Q3 2015, down 48% quarter-over-quarter.
- 2 funds opened new Biolase, Inc. positions in Q3 2015 and 4 closed out, a net change of -2 holders.
- The largest Biolase, Inc. buyer in Q3 2015 was Consonance Capital Management, an estimated $725K added.
- The largest Biolase, Inc. seller in Q3 2015 was Bank of New York Mellon, an estimated $130K sold.
Based on aggregated 13F filings for Q3 2015.